COMUNICADO #9

David, Chiriquí

30 de Julio, 2007.  Cumpliendo con nuestro compromiso de mantener una fuerza de ventas conciente de los beneficios y atributos de nuestro productos, llevamos a la provincia Chiricana, para todos los colaboradores de ventas de nuestros distribuidores, el seminario de capacitación y actualización de EQMattress^® y Beautyrest^® SPA, el cual se realizó con un rotundo éxito en los salones del Hotel Puerta del Sol.

Con la presencia de más 25 colaboradores RSA ("Retail Sales Associates") de la Provincia de Chiriquí, profundizamos, en un ambiente calido y ameno, las nuevas propiedades que los 3 nuevos modelos EQMattresss^® incorporan al mercado nacional.  Igualmente, actualizamos y profundizamos la información de ventas y especificaciones para Simmons^® Beautyrest^® Spa, producto Premium incorporado al mercado "retail" en Octubre de 2006; y repasamos el "line up" completo de la marca Simmons disponible en el mercado.

Observación

Todas las cifras expuestas en este informe son preliminares, las mismas están sujetas a revisión, comprobación y aprobación por los auditores externos de la empresa; y las mismas sólo pretenden mostrar la situación de la empresa en un momento determinado.  Las proyecciones futuras y presupuestos aquí delineados sólo serán utilizados como guía en las operaciones, pero los mismos no garantizan un desempeño o resultado específico.  Plastifom, S.A. se reservar el derecho de modificar este documento sin previo aviso.  Poliseal™, ColdBox™, Polifom™ y otros marcas utilizadas en esta nota son marcas registradas de Plastifom, S.A.

Trademarks

Simmons®, Beautyrest®, Backcare®, DeepSleep®, HealthSmart™, Säng™, Better Sleep Through Science® and other marks used in this note are trademarks of our affiliate, Dreamwell, Ltd. Other brand, product, service, and process names appearing on here are trademarks or service marks of their respective holders where indicated. Our trademarks may be not used publicly except with written permission from Dreamwell, Ltd. Reference to, description of or use of a product, service, publication or process on the document does not imply recommendation, approval, affiliation, or sponsorship of that product, service, publication or process by us.

“Safe Harbor” Statement under Private Securities Litigation Reform Act of 1995:

This release includes forward-looking statements that reflect Simmons’ Panama Licensee Operations current views about future events and financial performance. Words such as “estimates,” “expects,”,“anticipates,” “projects,” “plans,” “intends,” “believes,” “forecasts” and variations of such words or similar expressions that predict or indicate future events, results or trends, or that do not relate to historical matters, identify forward-looking statements. The forward-looking statements in this press release speak only as of the date of this release. These forward-looking statements are expressed in good faith and we believe there is a reasonable basis for them. However, there can be no assurance that the events, results or trends identified in these forward-looking statements will occur or be achieved. Investors should not rely on forward-looking statements because they are subject to a variety of risks, uncertainties, and other factors that could cause actual results to differ materially from Simmons’ expectations.  These factors include, but are not limited to: (i) competitive and pricing pressures in the bedding industry; (ii) legal and regulatory requirements; (iii) the success of new products, including HealthSmartTM, our new Beautyrest® premium priced products, our new DeepSleep® products, and the Beautyrest® Caresse® products; (iv) our relationships with our major suppliers; (v) fluctuations in costs of raw materials; (vi) our relationship with significant customers and licensees; (vii) our ability to increase prices on our products and the effect of these price increases on our unit sales; (viii) our labor relations; (ix) departure of key personnel; (x) encroachments on our intellectual property; (xi) product liability claims; (xii) our level of indebtedness; (xiii) interest rate risks; (xiv) compliance with covenants in our debt agreements; (xv) future acquisitions; (xvi) an increase in return rates and warranty claims; (xvii) our ability to achieve the expected benefits from the sales reorganization; and (xiii) other risks and factors identified from time to time in the Company’s reports filed with the Securities and Exchange Commission (“SEC”). We undertake no obligation to update or revise any